These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2122975)

  • 61. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
    Michel JB; Quertermous T
    J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells.
    van Hinsbergh VW; Kooistra T; Scheffer MA; Hajo van Bockel J; van Muijen GN
    Blood; 1990 Apr; 75(7):1490-7. PubMed ID: 2107884
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Constitutive biosynthesis of plasminogen activator inhibitor type-1 (PAI-1) by cultured human aortic endothelial cells independent of insulin.
    Klassen KJ; Nordt TK; Schneider DJ; Sobel BE
    Coron Artery Dis; 1993 Aug; 4(8):713-9. PubMed ID: 8261243
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A kinetic model of the circulatory regulation of tissue plasminogen activator.
    Chandler WL
    Thromb Haemost; 1991 Sep; 66(3):321-8. PubMed ID: 1746003
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cathepsin G--induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes?
    Pintucci G; Iacoviello L; Castelli MP; Amore C; Evangelista V; Cerletti C; Donati MB
    J Lab Clin Med; 1993 Jul; 122(1):69-79. PubMed ID: 8320493
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells.
    Grobmyer SR; Kuo A; Orishimo M; Okada SS; Cines DB; Barnathan ES
    J Biol Chem; 1993 Jun; 268(18):13291-300. PubMed ID: 7685759
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biochemical properties potentially rendering human brain microvasculature vulnerable to proteolytic injury associated with the use of fibrinolytic drugs.
    Okada H; Shatos MA; Doherty JM; Sobel BE; Fujii S
    Coron Artery Dis; 1999 Oct; 10(7):437-42. PubMed ID: 10562909
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells.
    Lopez S; Peiretti F; Bonardo B; Juhan-Vague I; Nalbone G
    Atherosclerosis; 2000 Oct; 152(2):359-66. PubMed ID: 10998463
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells.
    Cheng SL; Shen V; Peck WA
    Calcif Tissue Int; 1991 Nov; 49(5):321-7. PubMed ID: 1723649
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
    Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
    Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of Danhong Injection (丹红注射液) and its main components on anticoagulation and fibrinolysis in cultured vein endothelial cells.
    Zhang YY; Zhou HF; Yang JH; He Y; Chen XQ; Nishinari K; Wan HF; Wan HT
    Chin J Integr Med; 2016 Apr; 22(4):276-83. PubMed ID: 27059485
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells.
    Kugiyama K; Sakamoto T; Misumi I; Sugiyama S; Ohgushi M; Ogawa H; Horiguchi M; Yasue H
    Circ Res; 1993 Aug; 73(2):335-43. PubMed ID: 8330376
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways.
    Konkle BA; Kollros PR; Kelly MD
    J Biol Chem; 1990 Dec; 265(35):21867-73. PubMed ID: 1701436
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
    Ehrlich HJ; Gebbink RK; Preissner KT; Keijer J; Esmon NL; Mertens K; Pannekoek H
    J Cell Biol; 1991 Dec; 115(6):1773-81. PubMed ID: 1721912
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of fibrinolytic activities of human and bovine endothelial cells.
    Bartha K; Wojta J; Wagner OF; Binder BR
    Am J Physiol; 1988 Jun; 254(6 Pt 2):R885-90. PubMed ID: 3132861
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Measurement and characterization of free radical generation in reoxygenated human endothelial cells.
    Zweier JL; Kuppusamy P; Thompson-Gorman S; Klunk D; Lutty GA
    Am J Physiol; 1994 Mar; 266(3 Pt 1):C700-8. PubMed ID: 8166233
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering.
    Haslinger B; Goedde MF; Toet KH; Kooistra T
    Kidney Int; 2002 Nov; 62(5):1611-9. PubMed ID: 12371961
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1.
    Gaussem P; Anglés-Cano E
    Biochim Biophys Acta; 1991 Sep; 1079(3):321-9. PubMed ID: 1911857
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts.
    Teng YC; Lin QD; Lin JH; Ding CW; Zuo Y
    J Perinat Med; 2009; 37(4):343-8. PubMed ID: 19290852
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.